Orthofix Medical (OFIX) Competitors $13.91 -0.22 (-1.56%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock OFIX vs. ATRC, ATEC, IART, SRDX, ANGO, ARAY, RMTI, RSLS, ABT, and ISRGShould you be buying Orthofix Medical stock or one of its competitors? The main competitors of Orthofix Medical include AtriCure (ATRC), Alphatec (ATEC), Integra LifeSciences (IART), Surmodics (SRDX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), and Intuitive Surgical (ISRG). These companies are all part of the "health care equipment" industry. Orthofix Medical vs. AtriCure Alphatec Integra LifeSciences Surmodics AngioDynamics Accuray Rockwell Medical ReShape Lifesciences Abbott Laboratories Intuitive Surgical AtriCure (NASDAQ:ATRC) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, community ranking, profitability, analyst recommendations, valuation, risk, institutional ownership and media sentiment. Is ATRC or OFIX more profitable? AtriCure has a net margin of -9.61% compared to Orthofix Medical's net margin of -15.18%. AtriCure's return on equity of -6.80% beat Orthofix Medical's return on equity.Company Net Margins Return on Equity Return on Assets AtriCure-9.61% -6.80% -5.19% Orthofix Medical -15.18%-21.25%-13.29% Does the MarketBeat Community believe in ATRC or OFIX? AtriCure received 159 more outperform votes than Orthofix Medical when rated by MarketBeat users. Likewise, 69.77% of users gave AtriCure an outperform vote while only 62.20% of users gave Orthofix Medical an outperform vote. CompanyUnderperformOutperformAtriCureOutperform Votes57769.77% Underperform Votes25030.23% Orthofix MedicalOutperform Votes41862.20% Underperform Votes25437.80% Which has stronger valuation & earnings, ATRC or OFIX? AtriCure has higher earnings, but lower revenue than Orthofix Medical. AtriCure is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAtriCure$465.31M3.18-$44.70M-$0.95-31.48Orthofix Medical$799.49M0.68-$151.40M-$3.29-4.23 Do analysts rate ATRC or OFIX? AtriCure currently has a consensus price target of $50.67, indicating a potential upside of 69.40%. Orthofix Medical has a consensus price target of $23.33, indicating a potential upside of 67.75%. Given AtriCure's higher probable upside, research analysts plainly believe AtriCure is more favorable than Orthofix Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AtriCure 0 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 3.00Orthofix Medical 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to ATRC or OFIX? In the previous week, AtriCure had 21 more articles in the media than Orthofix Medical. MarketBeat recorded 24 mentions for AtriCure and 3 mentions for Orthofix Medical. AtriCure's average media sentiment score of 1.08 beat Orthofix Medical's score of 1.07 indicating that AtriCure is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AtriCure 12 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Orthofix Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, ATRC or OFIX? AtriCure has a beta of 1.65, meaning that its share price is 65% more volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500. Do institutionals & insiders hold more shares of ATRC or OFIX? 99.1% of AtriCure shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 3.5% of AtriCure shares are owned by insiders. Comparatively, 2.6% of Orthofix Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryAtriCure beats Orthofix Medical on 15 of the 17 factors compared between the two stocks. Get Orthofix Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for OFIX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OFIX vs. The Competition Export to ExcelMetricOrthofix MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$542.80M$4.38B$5.57B$7.82BDividend YieldN/A39.98%5.11%4.22%P/E Ratio-4.4430.6522.4418.48Price / Sales0.6854.19394.66103.91Price / CashN/A51.0838.1834.62Price / Book0.866.116.774.25Net Income-$151.40M$68.15M$3.22B$248.23M7 Day Performance3.57%1.33%3.09%3.29%1 Month Performance-13.39%-4.28%-0.14%2.43%1 Year Performance7.00%24.22%17.98%5.54% Orthofix Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OFIXOrthofix Medical3.1745 of 5 stars$13.91-1.6%$23.33+67.7%+7.9%$542.80M$799.49M-4.441,090Upcoming EarningsNews CoveragePositive NewsATRCAtriCure3.7217 of 5 stars$31.74-0.8%$49.44+55.8%+48.3%$1.56B$465.31M-33.411,050Earnings ReportAnalyst ForecastNews CoveragePositive NewsGap DownATECAlphatec4.1464 of 5 stars$10.64+0.8%$17.67+66.0%-11.0%$1.53B$611.56M-8.31700Upcoming EarningsShort Interest ↑IARTIntegra LifeSciences3.9916 of 5 stars$15.19-4.0%$22.71+49.5%-40.7%$1.17B$1.61B-168.763,720Upcoming EarningsSRDXSurmodics4.2289 of 5 stars$28.55+3.6%$50.00+75.1%+19.7%$408.15M$125.45M-28.27450Earnings ReportUpcoming EarningsAnalyst ForecastShort Interest ↑News CoveragePositive NewsGap DownANGOAngioDynamics4.2957 of 5 stars$9.25-2.8%$14.00+51.4%+64.6%$375.62M$283.32M-1.64760Positive NewsARAYAccuray2.8454 of 5 stars$1.45-2.0%N/A-27.0%$149.11M$453.14M-29.001,040Earnings ReportNews CoverageGap DownRMTIRockwell Medical4.3354 of 5 stars$1.02-1.0%$4.00+292.2%-25.7%$35.20M$101.49M-20.40300Short Interest ↓RSLSReShape Lifesciences0.4518 of 5 stars$0.38+23.7%N/A-96.3%$4.32M$8.01M-0.0350Short Interest ↑Negative NewsGap UpHigh Trading VolumeABTAbbott Laboratories4.8882 of 5 stars$130.00-0.7%$142.59+9.7%+21.7%$225.46B$41.95B16.99115,000Positive NewsISRGIntuitive Surgical4.6043 of 5 stars$468.32-3.0%$611.81+30.6%+37.6%$166.81B$8.35B73.0612,100Analyst Revision Related Companies and Tools Related Companies AtriCure Competitors Alphatec Competitors Integra LifeSciences Competitors Surmodics Competitors AngioDynamics Competitors Accuray Competitors Rockwell Medical Competitors ReShape Lifesciences Competitors Abbott Laboratories Competitors Intuitive Surgical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OFIX) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersTop performing AI play of the decade…? (The answer will shock you)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orthofix Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orthofix Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.